Skip to main content

Table 2 Univariate and multivariate Cox regression analysis of neoadjuvant immunotherapy vs. adjuvant immunotherapy

From: The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis

Variable

N (%)

Univariable analysis

Multivariable analysis

Hazard Ratio (95% CI)

P

Hazard Ratio (95% CI)

P

Immunotherapy

Neoadjuvant immunotherapy

408 (77.57)

1.06 (0.80–1.39)

0.703

1.06 (0.79–1.41)

0.714

Adjuvant immunotherapy

118 (22.43)

Ref

 

Ref

 
  1. The multivariable analysis was adjusted for the age at diagnosis, sex, race, income, education, place of living, treatment facility type, insurance status, comorbidity score, and year of diagnosis